Utilisation pattern of angiotension II inhibitors within a South African managed care organisation
Angiotensin II inhibitors or Angiotensin Receptor Blockers (ARB s) are the most recent addition to the suite of antihypertensives. They are also one of the most expensive of the drug classes. Since the introduction of the first ARB on the market, the merits of ARB s have been investigated. The me...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
2009
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10539/6963 |